Search Results - "Mac Gillavry, M.R."

Observer variability in the assessment of clinical probability in patients with suspected pulmonary embolism by Leclercq, M. G. L., Kruip, M. J. H. A., Mac Gillavry, M. R., Van Marwijk Kooy, M., Büller, H. R.

Get full text

Protein C and S and inflammation in sickle cell disease by Schnog, J.B., Mac Gillavry, M.R., van Zanten, A.P., Meijers, J.C.M., Rojer, R.A., Duits, A.J., ten Cate, H., Brandjes, D.P.M.

“…Reduced activity of naturally occurring anticoagulants (NOAC) protein C and protein S may contribute to vaso‐occlusion in sickle cell disease (SCD). We studied…”
Get full text

Low adjusted‐dose acenocoumarol therapy in sickle cell disease: A pilot study by Schnog, J.B., Kater, A.P., Mac Gillavry, M.R., Duits, A.J., Lard, L.R., van der Dijs, F.P.L., Brandjes, D.P.M., ten Cate, H., Statius van Eps, L.W., Rojer, R.A.

“…Vasoocclusion is a continuous process in sickle cell disease (SCD) and accumulates to significant end organ damage, mostly irrespective of the occurrence of…”
Get full text

Does the location of deep venous thrombosis of the leg determine the risk of the post‐thrombotic syndrome? by Bank, I., Mac Gillavry, M. R., Brandjes, D. P. M., Büller, H. R.

Get full text

No effect of acenocoumarol therapy on levels of endothelial activation markers in sickle cell disease by Schnog, J.B., Mac Gillavry, M.R., Rojer, R.A., Meijers, J.C.M., Fijnheer, R., ten Cate, H., Brandjes, D.P.M., Duits, A.J.

“…Sickle cell patients are characterized by a chronic inflammatory and hypercoagulable state, depicted by elevated levels of pro‐inflammatory cytokines,…”
Get full text